SS
To the subject of this post, there a number of parallels that can be drawn between the two companies. Wound healing included.
http://www.cellmid.com.au/content_common/pg-technology.seo
"Midkine modulates many important biological interactions such as cell growth, cell migration and cellular adherence. These functions are relevant to chronic inflammatory conditions, fibrosis, autoimmunity, cancer, ischemia, nerve growth/repair and wound healing"
The good news is the two companies IP appear to be complimentary.
- Forums
- ASX - By Stock
- AN1
- QBiotics v Cellmid
QBiotics v Cellmid, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable